Liver function tests as indicators of metabolic syndrome
- PMID: 21494072
- PMCID: PMC3304629
- DOI: 10.3350/kjhep.2011.17.1.9
Liver function tests as indicators of metabolic syndrome
Comment on
-
Association of serum alanine aminotransferase and γ-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease.Korean J Hepatol. 2011 Mar;17(1):27-36. doi: 10.3350/kjhep.2011.17.1.27. Korean J Hepatol. 2011. PMID: 21494075 Free PMC article.
References
-
- Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129:113–121. - PubMed
-
- Ekstedt M, Franzén LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44:865–873. - PubMed
-
- Piton A, Poynard T, Imbert-Bismut F, Khalil L, Delattre J, Pelissier E, et al. MULTIVIRC Group. Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. Hepatology. 1998;27:1213–1219. - PubMed
-
- Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, Del Vecchio E, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 2002;137:1–10. - PubMed
-
- Lee JK, Shim JH, Lee HC, Lee SH, Kim KM, Lim YS, et al. Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology. Hepatology. 2010;51:1577–1583. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical